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Proteins destined for the cell surface are translocated across the membrane of
the endoplasmic reticulum and then vectorially transported through the Golgi
complex to the plasma membrane (1). Core glycosylation occurs as the proteins
are translocated across the endoplasmic reticulum membrane. Initial processing
of the core (high mannose) glycosyl groups occurs as the proteins leave the
endoplasmic reticulum; terminal glycosylation and processing occurs in the Golgi
compartment.
A number of single and multiple base substitutions have been reported to
block the intracellular transport of the Sindbis virus glycoprotein (2), murine
class I antigen (3), A light chain (4), and influenza hemagglutinin (5). Several of
these are temperature-sensitive mutants in which defective transport can result
from increased aggregation (6), decreased oligomerization (7), or altered chain
folding (5) at nonpermissive temperatures. One other mutation involves disrup-
tion of an intrachain disulfide bond (3). These studies show that proper protein
conformation is essential for normal protein maturation and expression.
In addition, it has been proposed that there are specific signals embedded in
the primary protein sequence that are recognized by intracellular transport
systems (8). Interaction of a protein with a transport system would explain the
differential glycosylation and transport rates of proteins along a common mat-
urational pathway from the endoplasmic reticulum through the Golgi complex
and the ultimate sorting of proteins into different pathways. For example, a
signal embedded in the NH2 terminus of the yeast vacuolar glycoprotein, car-
boxypeptidase Y, appears to be necessary and sufficient to target the carboxy-
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peptidase to the vacuoles (9, 10). These protein-encoded signals are therefore
critical for determining a protein's fate in the cell .
Our laboratory has been examining mutations that alter the surface expression
of the murine class II Ia molecules. These Ia molecules, which are transmembrane
glycoproteins encoded by the H-2 MHC, are expressed primarily on the surface
of macrophages and B cells (11). There are two isotypic forms of Ia, I-A and I-
E, each of which is a heterodimer composed of noncovalently associated a and ,d
chains. Each a and 0 chain has two extracellular domains, a hydrophobic
transmembrane domain, and a short cytoplasmic tail. The most membrane-distal
(NH2-terminal) domain, is characterized by a high degree of intraspecies poly-
morphism. This allelic variation is the basis for la-restricted antigen recognition
by T cells (12, 13) .
We demonstrate in this report that a single conservative aminoacid substitution
in the ,Q1 domain of the A` e3 or Ea polypeptide can affect surface expression of I-
A or I-E molecules, respectively. In contrast, it has been demonstrated by our
laboratories (14-16) that the ,d1 domain can tolerate even nonconservative
changes without altering the level of surface expression for Ia. Therefore, the
mutation that we describe may identify a region of the Ia molecule that is critical
for intracellular transport and targeting to the cell surface.
Materials and Methods
Anti-la mAbs. The mAbs MKD6 (anti-I-A'), 17-227, 34-5-3, and 25-9-17 (anti-1-
A'''`'), I4-4-4, 40B, and 13/4 (anti-En'), and 34-1-4 (anti-E,1) were used in this study. These
antibodies were obtained from sources detailed in Glimcher et al . (17).
FAGS Analysis.
￿
Quantitative indirect immunofluorescence analysis was performed as
described (18) using an analyzer from Becton Dickinson & Co. (Mountain View, CA). For
analysis, 10' cells were incubated with 20 A of a previously titrated quantity of the mAb
indicated, followed by fluoresceinated goat anti-mouse H and L chain Ig (Cappel Labo-
ratories, Cochranville, PA). Levels of background staining were determined by incubation
of cells with the goat anti-mouse reagent in the absence of any anti-Ia mAb.
Cell Lines and Selection of Variants.
￿
Cells of the M 12 .4.1 (H-2") B cell lymphoma were
y irradiated with 1,000 rad and then subjected to negative immunoselection by immune
lysis with anti-Ia" mAbs plus complement. After three rounds of negative immunoselec-
tion, cells were surface negative for the particular Ia isotype recognized by the mAbs
used. Two surface-negative variants, the M 12 .A2 (I-A-/I-E+ ; described here) and the
M 12 .C3 (I-A-/I-E-; reference 17), were cloned from original bulk cell populations by
limiting dilution. The M12.A2 and M12.C3 cell lines were independently derived from
M 12 .4 .1 parental cells negatively selected with a combination of anti-I-A`' mAbs (34-5-3
and MKD6; M12.A2) or with a combination of anti-I-A' plus anti-I-E" mAbs (34-5-3,
14-4-4 and 34-1-4; M 12.C3).
The panel of T cell hybridomas used in these studies was produced and examined for
antigen specificity and Ia restriction as previously described (18). The AODH7A,
AODK1 .16.14, and 313026.1 cell lines were the kind gift of Dr. P. Marrack (National
Jewish Hospital, Denver, CO). T cellswere tested for activation in a standard IL-2 release
assay described elsewhere (18). Dose-response curves of antigen-presenting cells were
performed to ensure maximal stimulation and IL-2 release. The antigens human gamma
globulin, beef insulin, pork insulin, OVA (all from Sigma Chemical Co., St. Louis, MO),
and keyhole limpet hemocyanin (Calbiochem-Behring Corp., La Jolla, CA) were used in
culture as previously described (17, 18).
Cloning and Sequencing the A" and EN' Genes.
￿
cDNA libraries were constructed from
the surface-negative variants M12.A2 and M12.C3 using standard procedures (19).
Briefly, RNA was recovered from the variants and then enriched for the poly(A)+ fractionGRIFFITH ET AL.
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by passage over an oligo(dT)-cellulose column (New England Biolabs, Beverly, MA). This
material was used as a template for first strand synthesis with an oligo(dT) primer (New
England Biolabs) and reverse transcriptase (MolecularGenetics, St. Petersburg, FL). After
second-strand synthesis, Eco RI arms (New England Biolabs) were added and the cDNA
was ligated into the phage Xgt10 (Vector Cloning Systems, San Diego, CA). Unamplified
libraries were screened by Southern analysis with a full-length cDNA Esprobe (15) that
cross-reacts with Ag. Phage clones containing full-length copies of the Es (M12.C3) and
A" (M 12 .A2) were selected from initial pools of phage clones by restriction fragment
length polymorphism analysis. The M12.A2 Ad and M12.C3 E' inserts were then sub-
cloned into the appropriate M13 vectors (Amersham Corp., Arlington Heights, IL) for
sequencing by the dideoxy chain termination method (20). Various constructs were made
using the restriction sites shown in Fig. 2 and both strands of the Ad and E' cDNAs were
sequenced. All restriction enzymes were obtained from New England Biolabs.
Computer Resources.
￿
Computer resources used to carry out our studies were provided
by the National Institutes of Health-sponsored BIONET National Computer Resource
for Molecular Biology. This includes data base resources and algorithms from Chou and
Fasman (Brandeis University, Waltham, MA), Hopp and Woods(New York Blood Center,
NY), and Kyte and Doolittle (University of California at San Diego, La Jolla, CA) for
analysis of predicted protein structure and hydropathicity.
DNA-mediated Gene Transfer.
￿
A wild-type A#' gene in pBR327 (21) was cotransfected
into the M 12.A2 cell with the plasmid pMSV-neo, which contains the neomycin resistance
gene (22), using electroporation (23). Neomycin-resistant clones were selected and
screened for the expression of I-A' on the cell surface, as above.
Biochemical Analysis ofla Molecules.
￿
Procedures for the isolation of intrinsically radio-
labeled la molecules from B lymphoma cell lines have been previously described in detail
(24). M12.4.1 and M 12.A2 cells were biosynthetically labeled with [3SS]methionine,
solubilized with 0.5% Triton X-100, and immunoprecipitated with the anti-I-Ad reactive
mAb 17-227 covalently coupled to Sepharose. The immunoprecipitates were analyzed
with two-dimensional nonequilibrium pH gradient gel electrophoresis as previously de-
scribed (24).
Results
Characterization of the M12.A2 Surface Ia - Variant.
￿
The M 12 .A2 variant was
derived from the BALB/c (H-2d, I-A+/I-E') B cell lymphoma M12.4.1 after y
irradiation and negative immunoselection by immune lysis with a mixture of two
anti-1-Ad mAbs plus complement. The M 12.A2 variant, cloned from the bulk
population of treated cells by limiting dilution, is surface I-A-/I-E' by both
FRCS analysis (Table 1) and immunoelectron microscopy (data not shown).
Consistent with its surface phenotype, this variant will not present antigen to I-
M-restricted T cell hybridomas (Table II) . The defect in I-A-restricted antigen
presentation appears to be secondary to the loss of cell surface I-A molecules
and not to a general loss in ability to process and present antigen since M12 .A2
will present antigen normally to I-Ed-restricted T cells (Table I1).
The defect responsible for the surface I-A- phenotype of this cell is posttran-
scriptional since the M12 .A2 contains normal levels of messenger RNA for both
A. and A# in Northern analysis (data not shown). I-A molecules can be detected
in the cytoplasm of the M 12.A2 after permeabilization of the cell membrane
with formaldehyde treatment and staining with an anti-1-A' mAb (data not
shown). Two-dimensional gel analysis of biosynthetically labeled I-A molecules
immunoprecipitated with an anti-A' mAb allows ready identification of the a, (0,
and invariant chains (Fig. IA) . The pattern of oligosaccharide-induced hetero-
geneity in M 12.A2 is indistinguishable from the wild-type pattern (Fig. 1 B).544 A POINT MUTATION ALTERS TRANSPORT OF la MOLECULES
TABLE I
Surface Phenotype of the M12.4.1 Parent and Mutant M12.A2 and
M12.C3 Cell Lines
Schematic representation of a FACS analysis showing binding of the specified
mAbs to thesurface of theM12.4.1 parent cell line andtheM12.A2and M12.C3
mutants. +, strong staining above background; -, no staining above background.
TABLE II
Loss ofIa-restricted Antigen Presentation by M12-derived
Mutant Cell Lines
The M12.4.1 (I-A+/I-E+) wild-type parent and M12.C3 (I-A-/I-E-) and M12.A2
(I-A-/I-E+) variants were tested for their ability to present antigen to a panel of
autoreactive, alloreactive, and antigen-specific Iad-restricted T cell hybridomas.
The results, from astandard IL-2 releaseassay(18), arepresentedschematically.
The antigen specificity and la-restricting element are shown for each T cell
hybridoma. +, wild-type response; -, no IL-2 release abovebackground.
Three points can be made from this analysis. First, coprecipitation of the a
and ,Q chains with the anti-A0 mAb shows that the Ad:Ad heterodimer is formed
in the M12 .A2 cell and, therefore, that chain pairing has not been disrupted.
Second, detection of invariant chain indicates that the AQ:A, heterodimer forms
a complex with the invariant chain that is precipitable by the anti-Ad mAb.
Although it has been shown that the presence of the invariant chain is not an
absolute requirement for surface expression of Ia (25), it has been postulated
that formation of the a:0:invariant chain complex facilitates intracellular trans-
port (26) and may assure proper glycosylation of la (27). Third, the normal
pattern of glycosylation for both the a and (3 chains indicates that the Ad:A'~'
heterodimer has been transported from the endoplasmic reticulum to the Golgi
compartment; most of the induced complexity results from the processing of the
T cell
hybridoma Specificity M12
(wild-type)
Antigen-presenting cells
M12.C3 M12.A2
B3.C6 Auto:I-Ad + - -
B8/C3/X Pork insulin:I-Ad + - -
BCF1A20 Beef insulin:I-Ad + - -
LC26 Allo:l-Ed + - +
LC50 Allo:I-Ed + - +
LC62 Allo:I-Ed + - +
LC70 Allo:I-Ed + - +
LC76 Allo:l-Ed + - +
AODH7.1 HGG:I-Ed + - +
AODK1.16.14 KLH:I-Ed + - +
3D026.1 OVA:I-Ed + - +
Antigen-pre-
senting cell line 34-5-3
Anti-I-Ad
MKD6
mAbs
25-9-17 14-4-4
Anti-I-Ed
34-1-4
mAbs
40B 13/4
M12.4.1 + + + + + + +
M12.A2 - - - + + + +
M12.C3 - - - - - - -GRIFFITH ET AL.
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FIGURE 1 . Two-dimensional nonequilibrium pH gradient gel electrophoresis of 17-227
(anti-I-Ad) immunoprecipitates from (A) [s5S]methionine-labeled M12.A2 detergent extract
and (B) [s5S]methionine-labeled M12.4 .1 detergent extract . The Aa and A'# polypeptides are
labeled asaand S, respectively, and the invariant chain is labeled as Ii . Thepolypeptides were
first separatedby two-dimensional nonequilibriumpH gradient gel electrophoresis (horizontal
dimension : basic, left ; acidic, right) and then separatedby SDS-PAGE in the vertical dimension
(highest mol wt, top).
core (high mannose) N-linked glycosyl groups that has been shown to occur in
the medial and trans faces of the Golgi apparatus (28) .
Transfection ofM12.A2 with a wild-type Ab gene results in surface expression546
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of the A'O:A', heterodimer (data not shown). This does not rule out the possibility
that the Ad polypeptide also contains a mutation, but the successful expression
of I-A after DNA-mediated gene transfer of a wild-type Ab gene shows that a
hypothetical mutation in the Ad polypeptide is not sufficient to block intracellular
transport and cell surface expression of I-A molecules. These data suggest that
the defect in this variant is due to a structural mutation in the endogenous AO
polypeptide.
Characterization of the M12.C3 Surface la - Variant.
￿
The M12 .C3 cell line was
cloned by limiting dilution from irradiated, negatively selected M12.4.1 cells as
previously described (17). It had been negatively selected with a mixture of anti-
I-Ad and I-Ed mAbs and is surface I-A-/I-E- by FRCS analysis (Table I) and
immunoelectron microscopy (data not shown). M12.C3 will not present antigen
to any cloned antigen-specific, I-Ad- or I-Ed-restricted T cell hybridoma exam-
ined (Table II), but can participate in a class I-restricted response (29). The
M12.C3 cell line contains normal levels ofmRNA for Aa, Ep, and Eaby Northern
analysis (17).
Previous analysis of I-E molecules immunoprecipitated from the M12.C3
variant showed reduced heterogeneity of both the Eaand E, 3 chains, with the ER
chain having only the core-glycosylated form (17). After permeabilization, it is
possible to detect I-Ed polypeptides in the cytoplasm (data not shown). The
previously observed decrease in glycosylation-induced complexity of both Ed and
Ed would be consistent with an accumulation of I-E in the endoplasmic reticulum.
Transfection of the M 12.C3 variant with an E# gene resulted in surface
expression ofthe E'O:E. heterodimer on the cell surface (15). This DNA-mediated
gene transfer study shows that any hypothetical Ed mutations are not sufficient
to block intracellular transport or cell surface expression of I-E molecules. The
surface expression of the EO:Ea heterodimer therefore suggests that the defect in
the M12 .C3 variant is the result of a structural mutation in the endogenous Ea
polypeptide.
Sequence Analysis ofthe Mutant Ad and E,d e Genes.
￿
cDNA librarieswere prepared
from both variants and the Ad and Ed genes were cloned from the M12 .A2 and
M 12.C3 libraries, respectively . The coding regions of these genes were fully
sequenced in both orientations using the strategies shown in Fig. 2. Nucleotide
sequence data and predicted amino acid sequences, presented in Fig. 3, show
that both genes contain identical single base A -4 G transitions that result in a
predicted Asn -+ Ser substitution at residue 82 of the A0, domain (M 12.A2) and
at residue 83 of the E,31 domain (M 12 .C3). In addition, the A# gene contains a
single-base difference from the published d haplotype sequence in the leader
domain . This base change, A ---> G in the codon for residue -4, matches a wild-
type d haplotype sequence obtained in our laboratory. There are also two single-
base differences in the transmembrane and cytoplasmic regions that are silent
(changing the codons for amino acids 222 and 227 from CAC ---+ CAT and GGA
GGC, respectively). The Ad gene contains no mutations in the first 60 bases
of the 3' untranslated (UT)' region; the last 210 bases of the 3' UT region have
not been sequenced since the Ad ' 3' UT region contains an internal Eco RI site
' Abbreviation used in this paper:
￿
UT, untranslated.A 100 by
Sau
Psi
￿
Rsa Hha
B
Pst
100 by
Sau
Taq
￿
PstI Bgl
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Sau Hha Sau Pst Eco
Bgl Bgl
FIGURE 2.
￿
Partial restriction maps andsequence strategies for the A'# and Ed genes. The As
(A) and Ed (B) inserts were subcloned into the appropriate M13 vectors for sequencing by the
dideoxy chain termination method (20). Various constructs were made using the restriction
sites shown and both strands of the A° d and Ed cDNAs were fully sequenced. The coding
sequencesaredepicted by thick lines, whereas 5' leader and partial 3' untranslated sequences
are depicted by thinner lines. Bgl, Bgl II; Eco, Eco RI ; Hha, Hha I; Hind, Hind III; Hpa, Hpa
II; Pst, Pst I; Rsa, Rsa I; Sau, Sau 3AI; Taq, Taq I.
and these bases were lost during cloning. The M12.C3 Ed gene, which is wild
type in the leader and remaining coding domains, contains two base differences
from the published d haplotype sequence in the first 210 bases of the 3' UT
region. The last 100 bases of the 3' UT region were not sequenced.
Conformational and Hydropathicity Analyses of the Mutant Polypeptides.
￿
The
predicted amino acid substitution of Ser for Asn at residue 82 of the A' and
residue 83 of the E'a polypeptides is conservative since both Asn and Ser are
uncharged polar residues. Preliminary analysis of the Ad gene from the M12.A2
variant with the Chou and Fasman algorithm suggests that the Asn --> Ser
substitution causes no detectable change in the secondary structure of the AO
polypeptide (data not shown). Similarly, analysis with the Hoop and Doolittle,
and Wood and Kyte algorithms indicate that this mutation slightly decreases the
protein's predicted hydropathicity in the region of the mutation. Analysis of the
E# gene from the M12. C3 variant suggests that the Asn ---> Ser substitution may
disrupt the end of a a-pleated sheet and reinforce a possible turn sequence in
the folded ER polypeptide. The hydropathicity of this protein is also decreased
slightly by the substitution .
Discussion
The M12.A2 and M12-C3 variants were derived from the M12.4.1 B cell
lymphoma . Although these variants lack surface expression of I-A (M 12.A2) or548
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I-E (M12.C3) molecules, accumulation of the appropriate Ia molecule can be
detected in the cytoplasm. This accumulation appears to be the result of muta-
tions in the Ad and Ed# genes. Sequence analysis showed that both genes contain
an identical, shared mutation at amino acid 82/83 of the NH2-terminal ,Q1
domain that causes a change from Asn (wild-type) to Ser (mutant). In addition,
both genescontain unique mutations that do not alter the sequence of the mature
polypeptide. Possible explanations for the effect these mutations have on trans-
port of the Ia molecule are discussed below.
Failure to Transport theI-A and 1-E Polypeptides Is Likely Due to the Single-shared
Amino Acid Substitution. The shared mutation in the ,Q1 domain that results in
a change from Asn (wild-type) to Ser (mutant) is the likely cause for the altered
surface expression of Ia in the M12.A2 and M12.C3 cells. The M12.C3 E# gene
is wild-type in the leader and coding sequences except for the mutation in the
#1 domain that is shared with the M12.A2 A,3 gene. In addition to the shared
mutation, the M12.A2 A# gene contains silent mutations in the transmembrane
and cytoplasmic regions of the A, 3 polypeptide. The M12.A2 gene also contains
a single mismatch from the published As sequence in the leader domain. This
latter mismatch is apparently due to an error in the published Ad sequence since
the M12.A2 sequence is identical to a wild-type A# sequence obtained in our
laboratory (Fig. 3A). Therefore, the shared mutation is the only mutation that
alters the amino acid sequence in the mature A0 and Efl polypeptides.
The Shared Amino Acid Substitution Does NotApparently Alter Glycosylation of the
Ia Molecules. It has previously been shown that glycosylation can affect protein
folding and, ultimately, transport (6). It seems unlikely in this instance that
altered glycosylation is responsible for the observed defect in Ia expression,
however, since the wild-type Asn residue is not part of the N---Asn-X-Ser/Thr--
-C recognition sequence required for N-linked glycosylation (1). Further, Ia can
be expressed on the cell surface after treatment of cells with tunicamycin (32),
which blocks N-linked glycosylation (33), showing that N-linked glycosylation is
not critical for Ia expression.
It is also unlikely that an altered pattern of0-linked glycosylation at the mutant
Ser residue has blocked surface expression of Ia in the M12.A2 or M12.C3 cell.
The results presented in Fig. 1 show that the glycosylation pattern of the mutant
Ad (M 12. A2) and wild-typeAd (M 12.4.1) polypeptides are indistinguishable. This
indicates that additional 0-linked glycosylation of the mutant Ser has not oc-
curred and argues against a hypothetical alteration in glycosylation being respon-
sible for the defect in Ia expression observed in the M12.A2 and M12.C3 cells.
The Amino Acid Substitution in the (31 Domain May Alter Protein Conformation
and Create a Negative Transport Signal. Analysis of mutant Ia molecules that
contain single amino acid alterations at nonpolymorphic (15, 16, 34) or poly-
morphic (14, 35, 36) residues shows that an Ia molecule can tolerate even
nonconservative changes in the first domain without alteration of membrane
expression . This makes the profound effect (nonexpression) of the conservative
Asn --* Ser amino acid alteration we have described even more striking. One
possible explanation for the defect in Ia expression is that Ser at residue 82/83
creates a negative, "stop transport" signal.
As discussed above, this negative signal is not likely to be due to an altered
glycosylation of Ia. Rather, such a signal could be generated as the result of an550
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alteration in protein conformation. Any purported effect of the shared mutation
must allow, however, for the apparently normal interchain pairing, association
with the invariantchain, andcreation of mAb binding sites (which are dependent
upon chain association) that we have observed in the I-Ad and I-Ed molecules of
the M 12.A2 and M 12.C3 mutants.
These considerations appear to eliminate the possibility that the Ser disrupts
the formation of the intrachain disulfide bond that occurs at Cys residue 79/80.
Disruption of a disulfide bond, which has been shown to block intracellular
transport of a murine class I antigen (3), would have a substantial effect on
protein conformation. The binding of the MKD6 mAb to I-Ad molecules in the
cytoplasm of the M12.A2 variant (data not shown) further argues against disrup-
tion of this disulfide bond since binding of the MKD6 mAb is highly sensitive to
the protein conformation of the fl domain (D. J. McKean, unpublished obser-
vation).
Similarly, the shared mutation appears to differ from temperature-sensitive
mutations that block protein transport (2, 5) . These temperature-sensitive mu-
tations may cause aggregation (6), decrease oligomerization (7), or disrupt chain
folding at nonpermissive temperatures (5). Growth of the M12 .A2 at a range of
temperatures (30-40 °C) did not permit surface expression of the I-Ad molecule
(data not shown).
The Ser substitution might have a more subtle effect on tertiary protein
folding, intrachain, and/or interchain pairing. The physical blockade of transport
could be a secondary effect of this disruption ; e.g., through a reduced solubility
of the protein in the endoplasmic reticulum or Golgi complex. Our preliminary
analysis with the Chou and Fasman algorithm suggests that the Asn ---> Ser
substitution either does not alter (Ad) or minimally affects (Edd, reinforced turn)
these polypeptides. These differences may help account for the differential
processing of the respective mutant Ia molecules in the cytoplasm (I-Ad, wild-
type glycosylation pattern; I-Ed, only core glycosylation). Alternatively, the dif-
ferential localization may be secondary to the known slower metabolic turnover
of the I-E molecule (37) or other intrinsic properties of I-A and I-E that have
not yet been described. Any definitive statement about the effect of the single-
shared amino acid substitution on Ia structure must await the resolution of the
crystallographic structure of Ia.
The Shared Substitution May Delete a Positive Transport Signal.
￿
The independ-
ent derivation of the identical mutation (resulting in the Ser substitution) in both
Ia isotypes emphasizes the importance of this region in determining the structure
and function of Ia molecules. One intriguing possibility is that the single-base
substitution eliminates a positive transport signal. That is, the Asn at residue 82
(Ap) or 83 (Ed) may form part of a recognition sequence for an intracellular
system necessary for transport and targeting of Ia to the cell surface. Such a
recognition signal, which has been postulated to explain both organelle-specific
targeting and differential rate of expression for a number of proteins, has not
yet been clearly identified for a glycoprotein expressed on the cell surface.
A likely region to contain such a recognition signal in Ia is the 5-mer Cys-Arg-
His-Asn-Tyr, which immediately spans the affected Asn in M 12.A2 and M12.C3.
This 5-mer is conserved in almost every class II ,0-chain polypeptide whose gene
has been sequenced (Fig. 4), suggesting the evolutionary importance of thisW
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region in class II #-chain gene structure and function. Small linear sequences
have previously been shown to be capable of providing a specific signal that
affects intracellular transport. For example, the 4-mer sequence Lys-Asp-Glu-
Leu (K-D-E-L) has been reported to provide a "stop transport" signal for proteins
destined to remain in the endoplasmic reticulum (42). The R-chain 5-mer could
therefore provide the signal necessary to target and transport la to the cell
membrane.
There are three ,8-chain genes, the murine Au (38), A, 92 (39), and rat RT1 A0
(40), that encode altered sequences in this 5-mer region. The encoded AJu
polypeptide, which contains a single Hisel --+ Tyr8, amino acid substitution, is
expressed on the cell surface. As far as has been determined, the murine A,g2
gene does not encode a protein that is expressed on the cell surface. Expression
of the sequenced rat gene has not been examined. The successful cell surface
expression of the A" polypeptide suggests that if the 5-mer is a recognition
sequence, then some amino acid changes (e.g., Hiss, --* Tyrsl ) can be tolerated
but others (e.g., Asn82 -> Ser82) can not.
Additional, independently derived, surface la-negative variants are currently
being analyzed to see if they contain similar or identical mutations to that
describedin this report. The frequencyand type of mutationsthat can be defined
should provide additional insight into whether negative transport signals are
being created or positive signals are being eliminated. The class II glycoproteins
provide a well-defined model system to examine these issues.
Summary
We have selected la variants from the la+ (H-2d) M12.4.1 B cell lymphoma
that are negative on the cell surface for one or both la isotypes. The molecular
analysis of two such independently selected cell lines, M12.A2 and M12.C3, is
reported here. This analysis revealed that the genes encoding As (M 12.A2) and
Ed (M 12 .C3) contained identical single-nucleotide transitions that resulted in the
substitution of Ser (mutant) for Asn (wild-type) at residue 82/83 of the extracel-
lular NH2-terminal (membrane distal) /31 domain. This conservative substitution
caused a cytoplasmic accumulation of I-A or I-E molecules in the respective cell
line although predicted secondary-structure analysis suggests a minimal effect on
protein conformation. Thus, the mutation appears to have either created a
negative signal that stops transportor eliminated a positive signal that is required
for transport and targeting to the cell surface.
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